Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):e73–e79. doi: 10.1161/ATVBAHA.116.307481

Figure 1.

Figure 1

MicroRNAs in the atherosclerotic plaque that would benefit from nanoparticle (NP) delivery of RNA therapeutics (top). Schematic representation of different NP platforms (bottom).